| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 1,085 | 1,152 | 1,150 | 1,024 | 1,106 | 1,176 | 1,257 | 1,630 | 1,164 | 1,229 | 1,258 | 1,175 | 1,108 | 1,081 | 1,156 | 1,164 | 1,528 | 1,170 | 1,277 | 1,178 | 1,133 | 614 | 1,029 | 1,205 | 1,278 | 1,733 | 1,475 | 1,487 | 1,391 | 1,519 | 1,682 | 1,586 | 1,669 | 1,667 | 1,788 | 1,699 | 1,803 | 1,873 | 2,006 | 1,975 |
| Expenses | 1,022 | 986 | 1,087 | 1,066 | 1,091 | 1,059 | 1,097 | 1,023 | 1,045 | 1,071 | 1,138 | 1,069 | 1,907 | 1,034 | 1,172 | 1,193 | 1,069 | 996 | 1,028 | 1,012 | 987 | 709 | 875 | 987 | 1,055 | 1,135 | 1,178 | 1,180 | 1,157 | 1,237 | 1,304 | 1,283 | 1,372 | 1,386 | 1,440 | 1,396 | 1,405 | 1,516 | 1,613 | 1,553 |
| EBITDA | 62 | 166 | 62 | -42 | 15 | 118 | 160 | 607 | 118 | 158 | 120 | 106 | -799 | 47 | -16 | -29 | 459 | 174 | 250 | 166 | 146 | -96 | 155 | 218 | 223 | 598 | 297 | 307 | 234 | 282 | 378 | 302 | 297 | 282 | 349 | 303 | 398 | 356 | 393 | 422 |
| Operating Profit % | 3 % | 4 % | -2 % | -5 % | -2 % | 6 % | 8 % | 10 % | 7 % | 7 % | 5 % | 5 % | -76 % | 1 % | -3 % | -8 % | 10 % | 13 % | 15 % | 13 % | 11 % | -17 % | 12 % | 16 % | 16 % | 20 % | 19 % | 20 % | 16 % | 17 % | 19 % | 18 % | 16 % | 16 % | 19 % | 17 % | 21 % | 18 % | 19 % | 19 % |
| Depreciation | 61 | 53 | 0 | 0 | 72 | 48 | 52 | 60 | 63 | 59 | 61 | 59 | 60 | 57 | 56 | 60 | 60 | 71 | 71 | 70 | 80 | 72 | 74 | 73 | 72 | 73 | 75 | 76 | 77 | 74 | 77 | 83 | 82 | 79 | 84 | 87 | 92 | 91 | 95 | 97 |
| Interest | 37 | 34 | 30 | 32 | 38 | 42 | 46 | 75 | 67 | 64 | 66 | 63 | 64 | 76 | 85 | 111 | 65 | 51 | 49 | 48 | 57 | 41 | 42 | 42 | 41 | 38 | 40 | 38 | 30 | 31 | 33 | 33 | 32 | 32 | 32 | 33 | 35 | 35 | 36 | 45 |
| Profit Before Tax | -22 | 88 | 44 | -58 | -96 | 28 | 62 | 472 | -11 | 35 | -7 | -17 | -924 | -87 | -157 | -201 | 334 | 52 | 130 | 48 | 9 | -208 | 38 | 103 | 110 | 486 | 182 | 193 | 126 | 176 | 268 | 186 | 183 | 171 | 233 | 183 | 271 | 230 | 261 | 279 |
| Tax | -10 | -9 | -17 | -29 | -8 | 3 | 24 | 19 | 26 | 12 | 17 | 3 | -9 | -34 | -15 | -20 | 183 | -26 | 6 | 118 | 50 | -20 | 23 | 49 | 48 | 56 | 51 | 51 | 39 | 42 | 50 | 44 | 45 | 47 | 49 | 49 | 68 | 56 | 68 | 25 |
| Net Profit | -12 | 97 | 61 | -29 | -88 | 25 | 38 | 453 | -38 | 23 | -24 | -19 | -914 | -53 | -142 | -180 | 151 | 78 | 124 | -69 | -41 | -188 | 16 | 54 | 62 | 431 | 131 | 142 | 87 | 134 | 218 | 142 | 138 | 124 | 184 | 134 | 203 | 174 | 193 | 254 |
| EPS in ₹ | -0.38 | 2.01 | 1.19 | -0.65 | -1.91 | 0.35 | 0.68 | 9.49 | -0.79 | 0.10 | -0.88 | -0.71 | -17.97 | -1.36 | -3.21 | -3.06 | 1.80 | 0.90 | 1.47 | -1.01 | -0.59 | -2.37 | -0.05 | 0.40 | 0.57 | 3.49 | 1.42 | 1.55 | 0.90 | 1.62 | 2.71 | 1.72 | 1.76 | 1.48 | 2.30 | 1.78 | 2.37 | 2.20 | 2.34 | 3.28 |
Fortis Healthcare
642.30
-3.40
(-0.53%)
There are new updates from the company19 hours ago
View
Market Cap
48,490.96 Cr
EPS
7.93
PE Ratio
61.76
Dividend Yield
0.15 %
Industry
Healthcare Services52 Week High
744.50
52 Week Low
406.00
PB Ratio
6.21
Debt to Equity
0.14
Sector
Hospitals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from13 analysts
Company News
View All News
Fortis Healthcare Faces Legal Hurdle in Sale of Shrimann Hospital3 days ago
Fortis Healthcare has reported that an ex-parte injunction order has been issued, restraining the sale of Shrimann Hospital. In response, Shrimann Hospital is seeking an amicable settlement to vacate the injunction order. This legal development could potentially impact Fortis Healthcare's plans regarding the hospital.
Fortis Healthcare Faces Injunction on Sale of Shrimann Hospital5 days ago
Fortis Healthcare has reported that an ex-parte injunction order has been issued, preventing the sale of Shrimann Hospital. In response, Shrimann Hospital is seeking an amicable settlement to have the injunction order vacated. This legal development could potentially impact Fortis Healthcare's strategic plans or asset management.
Fortis Healthcare Expected to See $24.1 Million Inflow Due to FTSE Index Rejig5 days ago
Fortis Healthcare is anticipated to experience an inflow of $24.1 million (approximately Rs 2.07 billion) today at 3 PM due to a rebalancing of the FTSE index. This adjustment in the index composition is likely to impact the stock's trading volume and potentially its price.
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,132.50 | #1 1,10,093.96 | 102.90 | 5,584.10 | 18.77 | #1 1,058 | -17.46 | 58.85 | |
6,507.00 | 93,560.68 | 71.54 | #1 19,165.50 | 14.74 | 917 | 49.14 | 55.76 | |
1,667.45 | 34,076.14 | 42.51 | 5,093.40 | 10.96 | 790 | 2.66 | 61.10 | |
1,226.70 | 32,947.61 | 64.67 | 2,759.20 | #1 25.09 | 326 | 15.71 | 54.11 | |
616.65 | 24,674.57 | 70.52 | 2,511.20 | 12.94 | 336 | 20.76 | 59.35 | |
435.40 | 21,748.80 | 83.71 | 3,723.70 | 22.85 | 205 | -69.22 | 55.20 | |
1,328.75 | 13,493.68 | 56.82 | 1,334.00 | 10.76 | 218 | 10.06 | 52.96 | |
5,232.00 | 11,571.26 | #1 27.61 | 599.90 | 11.69 | 58 | 8.85 | 43.18 | |
1,689.45 | 11,077.05 | 57.85 | 1,095.50 | 21.32 | 177 | 20.14 | 74.72 | |
Fortis Healthcare this company | 642.30 | #3 48,490.96 | #5 61.76 | #2 6,931.20 | #10 8.99 | #4 645 | #1 89.49 | 55.89 |
Growth Rate
Revenue Growth
8.99 %
Net Income Growth
1.93 %
Cash Flow Change
33.79 %
ROE
-3.46 %
ROCE
14.14 %
EBITDA Margin (Avg.)
3.01 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 |
| Fixed Assets | 4,218 | 3,776 | 5,419 | 4,992 | 8,477 | 8,802 | 8,799 | 9,416 | 9,426 | 9,874 |
| Current Assets | 1,636 | 1,434 | 1,775 | 1,282 | 1,667 | 941 | 1,037 | 1,133 | 1,406 | 1,421 |
| Capital Work in Progress | 228 | 201 | 268 | 226 | 450 | 204 | 165 | 194 | 228 | 542 |
| Investments | 616 | 1,449 | 1,878 | 1,732 | 270 | 175 | 186 | 104 | 210 | 230 |
| Other Assets | 2,554 | 1,807 | 2,152 | 1,672 | 2,755 | 2,167 | 2,005 | 2,172 | 2,569 | 2,643 |
| Total Liabilities | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 |
| Current Liabilities | 1,602 | 1,476 | 1,927 | 2,134 | 3,591 | 2,579 | 1,233 | 1,269 | 1,426 | 3,170 |
| Non Current Liabilities | 1,813 | 1,616 | 1,480 | 1,171 | 1,248 | 1,563 | 3,204 | 3,607 | 2,907 | 1,563 |
| Total Equity | 4,201 | 4,140 | 6,311 | 5,317 | 7,113 | 7,206 | 6,718 | 7,008 | 8,100 | 8,556 |
| Reserve & Surplus | 3,585 | 3,534 | 4,626 | 3,543 | 5,846 | 5,906 | 5,365 | 5,423 | 6,487 | 6,908 |
| Share Capital | 463 | 463 | 518 | 519 | 755 | 755 | 755 | 755 | 755 | 755 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -66 | -38 | 225 | -513 | 799 | -627 | 212 | -153 | -22 | 125 |
| Investing Activities | 213 | 122 | -1,001 | -333 | -3,279 | 64 | -131 | -501 | -373 | -889 |
| Operating Activities | 24 | 195 | 967 | 493 | -179 | 172 | 486 | 865 | 822 | 1,100 |
| Financing Activities | -304 | -354 | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | -87 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 26.32 % | 0.00 % | 23.24 % | 23.31 % | 25.26 % | 26.77 % |
| DIIs | 13.44 % | 15.20 % | 15.66 % | 15.50 % | 16.72 % | 17.44 % | 19.94 % | 20.38 % | 20.70 % | 22.16 % | 26.55 % | 29.35 % | 31.15 % | 32.31 % | 30.73 % | 30.05 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 13.96 % | 15.16 % | 15.98 % | 14.89 % | 13.96 % | 13.58 % | 12.92 % | 12.39 % | 12.05 % | 11.80 % | 11.13 % | 11.04 % | 10.82 % | 10.47 % | 10.36 % | 10.21 % |
| Others | 41.43 % | 38.47 % | 37.20 % | 38.44 % | 38.15 % | 37.82 % | 35.98 % | 36.06 % | 36.08 % | 34.86 % | 4.83 % | 28.44 % | 3.63 % | 2.75 % | 2.48 % | 1.81 % |
| No of Share Holders | 0 | 1,09,889 | 1,44,634 | 1,66,743 | 1,54,572 | 1,56,881 | 1,60,762 | 1,58,455 | 1,37,894 | 1,35,047 | 1,31,516 | 1,35,664 | 1,57,165 | 1,54,260 | 2,04,184 | 2,21,750 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.15 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Closure of Trading Window
19 hours ago
19 hours agoAnnouncement under Regulation 30 (LODR)-Updates on Acquisition5 days ago
5 days agoUpdate On Acquisition Announcement Dated February 14 20255 days ago
5 days ago Shareholder Meeting / Postal Ballot-Scrutinizer"s Report6 days ago
6 days agoShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot6 days ago
6 days agoDisclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015.6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2025
Feb 19, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Feb 14, 2025Acquisition Of Shrimann Superspecialty Hospital.Feb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-AcquisitionFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Feb 08, 2025Statement Of Deviation And Variation.Feb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 07, 2025
Feb 07, 2025Compliances-Reg. 54 - Asset Cover details Feb 07, 2025
Feb 07, 2025Integrated Filing (Financial)Feb 07, 2025
Feb 07, 2025Updated Policy Of Materiality Of EventsFeb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationFeb 07, 2025
Feb 07, 2025Outcome Of The Board Meeting Under Regulation 30 And Regulation 51(2) And 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements)
Regulations 2015Feb 07, 2025
Feb 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And Regulation 51(2) And 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) RegulatFeb 07, 2025
Feb 07, 2025Reschedule Of Investor/Analysts MeetFeb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Feb 07, 2025Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015.Feb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2025
Jan 29, 2025Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 29, 2025
Jan 29, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 17, 2025
Jan 17, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 16, 2025
Jan 16, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Jan 16, 2025
Jan 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2025
Jan 15, 2025Announcement Under Regulation 30 Of SEBI (LODR) - Change In DesignationDec 27, 2024
Dec 27, 2024Appointment Of Chairman.Dec 27, 2024
Dec 27, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 27, 2024
Dec 27, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateDec 27, 2024
Dec 27, 2024Board Meeting Outcome for Outcome Of The Board Meeting-December 27 2024Dec 27, 2024
Dec 27, 2024Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2024
Nov 13, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 09, 2024
Nov 09, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 09, 2024
Nov 09, 2024Announcement under Regulation 30 (LODR)-Investor PresentationNov 08, 2024
Nov 08, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 08, 2024
Nov 08, 2024Un-Audited Financial Results For Half Year Ended September 30, 2024Nov 08, 2024
Nov 08, 2024Board Meeting Outcome for Outcome Of Board MeetingNov 08, 2024
Nov 08, 2024Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).Nov 07, 2024
Nov 07, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2024
Nov 05, 2024Disclosure Under Regulation 30 Of (SEBI Listing Regulations)- Regarding Fortis Trademarks And Allied TrademarksOct 30, 2024
Oct 30, 2024Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Oct 30, 2024
Oct 30, 2024Announcement Under Regulation 30- CCI ApprovalOct 29, 2024
Oct 29, 2024Technical Indicators
RSI(14)
Neutral 55.89
ATR(14)
Less Volatile 23.21
STOCH(9,6)
Neutral 64.87
STOCH RSI(14)
Overbought 87.21
MACD(12,26)
Bullish 4.17
ADX(14)
Weak Trend 14.80
UO(9)
Bearish 55.19
ROC(12)
Uptrend And Accelerating 2.57
WillR(14)
Neutral -32.34
About Fortis Healthcare
Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(17 Years,
46 days)
Chairperson NameLeo Puri
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
